Values First Advisors Inc. Grows Stock Holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC)

Values First Advisors Inc. grew its holdings in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) by 9.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,588 shares of the company’s stock after purchasing an additional 467 shares during the quarter. Values First Advisors Inc.’s holdings in iRhythm Technologies were worth $504,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Creative Planning purchased a new position in iRhythm Technologies during the second quarter worth about $385,000. Exchange Traded Concepts LLC lifted its holdings in shares of iRhythm Technologies by 34.8% during the 3rd quarter. Exchange Traded Concepts LLC now owns 11,078 shares of the company’s stock worth $822,000 after acquiring an additional 2,859 shares during the period. nVerses Capital LLC lifted its holdings in shares of iRhythm Technologies by 400.0% during the 3rd quarter. nVerses Capital LLC now owns 2,000 shares of the company’s stock worth $148,000 after acquiring an additional 1,600 shares during the period. Allspring Global Investments Holdings LLC boosted its position in shares of iRhythm Technologies by 9.3% in the third quarter. Allspring Global Investments Holdings LLC now owns 519,973 shares of the company’s stock worth $38,603,000 after acquiring an additional 44,387 shares during the last quarter. Finally, Bank Pictet & Cie Europe AG grew its holdings in iRhythm Technologies by 22.3% in the third quarter. Bank Pictet & Cie Europe AG now owns 3,105 shares of the company’s stock valued at $231,000 after purchasing an additional 567 shares during the period.

iRhythm Technologies Trading Up 4.0 %

IRTC stock opened at $111.17 on Thursday. The stock has a 50-day simple moving average of $97.43 and a 200-day simple moving average of $81.88. The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00. iRhythm Technologies, Inc. has a 1 year low of $55.92 and a 1 year high of $124.11.

Insider Buying and Selling at iRhythm Technologies

In other iRhythm Technologies news, insider Patrick Michael Murphy sold 2,492 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $85.89, for a total value of $214,037.88. Following the completion of the transaction, the insider now directly owns 35,327 shares of the company’s stock, valued at $3,034,236.03. This represents a 6.59 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.68% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on IRTC shares. Truist Financial increased their price target on shares of iRhythm Technologies from $85.00 to $111.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th. Wells Fargo & Company restated an “equal weight” rating and set a $86.00 price objective on shares of iRhythm Technologies in a report on Tuesday, December 3rd. Canaccord Genuity Group lifted their target price on iRhythm Technologies from $125.00 to $152.00 and gave the company a “buy” rating in a report on Monday, December 9th. Robert W. Baird dropped their price target on iRhythm Technologies from $100.00 to $79.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Finally, Oppenheimer lifted their price objective on iRhythm Technologies from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, iRhythm Technologies has an average rating of “Moderate Buy” and a consensus price target of $108.45.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.